ATE445587T1 - Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i - Google Patents

Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i

Info

Publication number
ATE445587T1
ATE445587T1 AT06771215T AT06771215T ATE445587T1 AT E445587 T1 ATE445587 T1 AT E445587T1 AT 06771215 T AT06771215 T AT 06771215T AT 06771215 T AT06771215 T AT 06771215T AT E445587 T1 ATE445587 T1 AT E445587T1
Authority
AT
Austria
Prior art keywords
crystal form
cinacalcet hydrochloride
hydrochloride crystal
producing cinacalcet
producing
Prior art date
Application number
AT06771215T
Other languages
English (en)
Inventor
Revital Lifshitz-Liron
Sharon Avhar-Maydan
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE445587T1 publication Critical patent/ATE445587T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/90—Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
AT06771215T 2005-05-23 2006-05-23 Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i ATE445587T1 (de)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US68415205P 2005-05-23 2005-05-23
US69698105P 2005-07-05 2005-07-05
US69711105P 2005-07-06 2005-07-06
US69861305P 2005-07-11 2005-07-11
US70123205P 2005-07-20 2005-07-20
US70291805P 2005-07-26 2005-07-26
US70691005P 2005-08-09 2005-08-09
US73005005P 2005-10-24 2005-10-24
US73208305P 2005-10-31 2005-10-31
US73300805P 2005-11-02 2005-11-02
US73466905P 2005-11-07 2005-11-07
US73512605P 2005-11-08 2005-11-08
US73882705P 2005-11-21 2005-11-21
US74178705P 2005-12-01 2005-12-01
US75091005P 2005-12-15 2005-12-15
US79480406P 2006-04-24 2006-04-24
PCT/US2006/020304 WO2006127933A1 (en) 2005-05-23 2006-05-23 Processes for preparing cinacalcet hydrochloride crystal form i

Publications (1)

Publication Number Publication Date
ATE445587T1 true ATE445587T1 (de) 2009-10-15

Family

ID=37101358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06771215T ATE445587T1 (de) 2005-05-23 2006-05-23 Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i

Country Status (12)

Country Link
US (2) US7247751B2 (de)
EP (3) EP1883618B1 (de)
JP (3) JP4638491B2 (de)
KR (2) KR20070088485A (de)
CN (1) CN101180261A (de)
AT (1) ATE445587T1 (de)
CA (2) CA2606099A1 (de)
ES (1) ES2334260T3 (de)
IL (2) IL185108A0 (de)
MX (1) MX2007000983A (de)
TW (1) TW200716512A (de)
WO (2) WO2006127932A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2001832A1 (de) * 2006-03-23 2008-12-17 Amgen Inc. Verfahren und zusammensetzung zur herstellung und verwendung von cinacalcet-polymorphen
WO2008000422A1 (en) * 2006-06-27 2008-01-03 Sandoz Ag Amorphous form of cinacalcet
US20090197970A1 (en) * 2006-06-27 2009-08-06 Sandoz Ag Crystalline form of cinacalcet
EP1913941A1 (de) * 2006-10-19 2008-04-23 Sandoz AG Polymorphe Formen und Solvaten von Cinacalcet Hydrochlorid
US20080181959A1 (en) * 2006-09-01 2008-07-31 Ilan Zalit Solid composites of a calcium receptor-active compound
WO2008058236A2 (en) * 2006-11-08 2008-05-15 Dr. Reddy's Labortories, Ltd. Methods for preparing cinacalcet hydrochloride
EP1968932A1 (de) * 2006-11-20 2008-09-17 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von cinacalcet
US20090137837A1 (en) * 2007-06-21 2009-05-28 Amgen Inc. Methods of synthesizing cinacalcet and salts thereof
ITMI20071261A1 (it) 2007-06-22 2008-12-23 Dipharma Francis Srl Procedimento per la preparazione di cinacalcet
US20090093652A1 (en) * 2007-08-16 2009-04-09 Michal Rafilovich Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
CA2700070A1 (en) 2007-09-18 2009-03-26 Medichem, S.A. Improved process for preparing cinacalcet hydrochloride
US7696372B2 (en) * 2007-10-01 2010-04-13 Ascenta Therapeutics, Inc. Process for preparing R-gossypol L-phenylalaninol dienamine
WO2010071689A2 (en) * 2008-05-05 2010-06-24 Medichem, S.A. Process for controlling the particle size of a 3-(trifluoromethyl)phenyl]-1-aminopropane derivative
EP2321256B1 (de) * 2008-06-18 2014-11-12 ERREGIERRE S.p.A. Verfahren zur synthese von cinacalcet hydrochlorid
US20110178326A1 (en) * 2008-08-06 2011-07-21 Actavis Group Ptc Ehf Unsaturated cinacalcet salts and processes for preparing cinacalcet hydrochloride
WO2010067204A1 (en) 2008-12-08 2010-06-17 Actavis Group Ptc Ehf Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
JP5503670B2 (ja) 2009-02-19 2014-05-28 ザック システム エス．ピー．エー． シナカルセト塩酸塩の製造方法
EP2403823B1 (de) 2009-03-05 2015-10-21 Cipla Limited Verfahren zur herstellung von cinacalcet und salzen davon und zwischenprodukte zur verwendung in dem verfahren
WO2010128388A2 (en) 2009-05-08 2010-11-11 Aurobindo Pharma Limited An improved process for the preparation of intermediate compounds useful for the preparation of cinacalcet
BR112012008332B8 (pt) 2009-09-10 2021-05-25 Fis Fabbrica Italiana Sintetici Spa intermediário de cinacalcet, seu processo de preparação e processo para preparação de cinacalcet
US8722732B2 (en) 2009-09-29 2014-05-13 Nektar Therapeutics Oligomer-calcimimetic conjugates and related compounds
IT1396623B1 (it) 2009-11-26 2012-12-14 Dipharma Francis Srl Procedimento per la preparazione di cinacalcet e suoi intermedi
CZ303627B6 (cs) * 2011-11-25 2013-01-16 Zentiva, K.S. Zpusob výroby Cinacalcetu
CN103450027B (zh) 2012-05-29 2015-07-29 上海京新生物医药有限公司 盐酸西那卡塞的制备方法
FR2995307A1 (fr) 2012-09-07 2014-03-14 Prod Chim Auxiliaires Et De Synthese Procede de preparation du cinacalcet et de ses sels pharmaceutiquement acceptables
CN103739500B (zh) * 2012-12-27 2016-03-23 国药一心制药有限公司 一种盐酸西那卡塞的合成与精制方法
CN103193655B (zh) * 2013-04-15 2015-06-24 山东新华制药股份有限公司 盐酸西那卡塞晶型ⅰ的制备方法
CN104512864B (zh) * 2013-09-30 2017-08-22 中国石油化工股份有限公司 一种低温脱除微量碳氧化物的方法
SG10202012791TA (en) 2013-11-15 2021-01-28 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
BR102015025502B1 (pt) * 2015-04-30 2022-06-21 Aegerion Pharmaceuticals, Inc Composição de lomitapida, tablete, produto de lomitapida, métodos para analisar uma composição de amostra de lomitapida e para determinar uma quantidade de uma impureza em uma amostra da composição
CN104892428A (zh) * 2015-06-05 2015-09-09 南京辰逸生物科技有限公司 一种盐酸西那卡塞的制备方法
CN106610404B (zh) * 2015-10-21 2019-01-15 华仁药业股份有限公司 采用hplc法检测盐酸西那卡塞同分异构体的方法
CN105439818B (zh) * 2015-12-31 2017-11-28 苏州汇和药业有限公司 一种西那卡塞中间体3‑(3‑三氟甲基苯基)丙醇的合成方法
CN107879939A (zh) * 2016-09-30 2018-04-06 上海天慈生物谷生物工程有限公司 一种制备 n‑((1r)‑1‑(1‑萘基)乙基)‑3‑(3‑(三氟甲基)苯基)丙‑1‑胺盐酸盐的方法
KR20200022712A (ko) * 2018-08-23 2020-03-04 주식회사 오스코텍 8-브로모-2-(1-메틸피페리딘-4-일아미노)-4-(4-페녹시페닐아미노)피리도[4,3-d]피리미딘-5(6H)-온 염산염의 결정다형체 및 그 제조방법
CN109096119B (zh) * 2018-10-29 2019-10-25 江苏永安制药有限公司 一种制备盐酸西那卡塞的方法
CN110041206B (zh) * 2019-04-29 2021-10-19 梯尔希（南京）药物研发有限公司 一种西那卡塞杂质的制备方法
CN111153832B (zh) * 2020-01-20 2022-02-25 广州九植医药科技有限公司 一种西那卡塞杂质的制备方法
TW202517274A (zh) * 2023-06-30 2025-05-01 韓商鐘根堂股份有限公司 化合物之新穎製備方法及新結晶形式

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966988A (en) 1989-02-17 1990-10-30 Chevron Research Company Process for preparing acetonitrile 3-trifluoromethyl benzene
US6011068A (en) 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) * 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE69535461T2 (de) 1994-10-21 2008-09-25 NPS Pharmaceuticals, Inc., Salt Lake City Kalzium-rezeptor aktive verbindungen
US5648541A (en) 1995-09-28 1997-07-15 Nps Pharmaceuticals, Inc. Chiral reductions of imines leading to the syntheses of optically active amines
EP0907631B1 (de) * 1996-05-01 2003-06-18 Nps Pharmaceuticals, Inc. Verbindungen , die auf anorganische ionen-rezeptoren wirken
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
HUE044822T2 (hu) * 2003-09-12 2019-11-28 Amgen Inc Cinakalcet HCl gyors feloldódású készítménye

Also Published As

Publication number Publication date
EP1883618B1 (de) 2009-10-14
KR20070083471A (ko) 2007-08-24
US7294735B2 (en) 2007-11-13
WO2006127932A3 (en) 2007-02-01
JP2010280715A (ja) 2010-12-16
US20070099998A1 (en) 2007-05-03
CA2606099A1 (en) 2006-11-30
TW200716512A (en) 2007-05-01
IL185494A0 (en) 2008-01-06
EP1975150A1 (de) 2008-10-01
EP1805135A2 (de) 2007-07-11
CN101180261A (zh) 2008-05-14
MX2007000983A (es) 2007-04-16
JP2008507565A (ja) 2008-03-13
ES2334260T3 (es) 2010-03-08
WO2006127932A2 (en) 2006-11-30
IL185108A0 (en) 2007-12-03
WO2006127933A1 (en) 2006-11-30
JP4638491B2 (ja) 2011-02-23
US7247751B2 (en) 2007-07-24
US20070060645A1 (en) 2007-03-15
KR20070088485A (ko) 2007-08-29
WO2006127933A8 (en) 2007-08-30
EP1883618A1 (de) 2008-02-06
JP2008507566A (ja) 2008-03-13
CA2605736A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
ATE445587T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
ATE544754T1 (de) Verfahren zur herstellung von ivabradinhydrochlorid
DE502005004577D1 (de) Verfahren zur herstellung von dinitrilen
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
DE502005010476D1 (de) Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
DE602004004663D1 (de) Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen
EP1792899A4 (de) Verfahren zur herstellung von optisch aktiven aminderivaten
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
DE602005026987D1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ATE476411T1 (de) Verfahren zur herstellung von 3-pentennitril
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE489015T1 (de) Verfahren zur herstellung von verschlüssen
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
EP1829868A4 (de) Verfahren zur herstellung von (4,5-dihydroxyisoxazol-3-yl)thiocarboxamidinsalzen
ATE430140T1 (de) Verfahren zur herstellung von ä1,4,5ü- oxadiazepinderivaten
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
ATE552234T1 (de) Cyclohexanderivate und verfahren zu deren herstellung
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE602006021355D1 (de) Ein Verfahren zur Herstellung von Tolterodin
DE602008002440D1 (de) Verfahren zur herstellung von n-(2-chlor-4-methyl-3-thienyl)-1h-benzimidazol- 2-amin hydrochlorid und zwischenprodukte dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties